EUVIMEDEUVIMED entdecken
BeobachtungsstudieQuerschnittstudie

Impact of prior cryptococcal antigen screening on in-hospital mortality in cryptococcal meningitis or fungaemia among HIV-seropositive individuals in South Africa: a cross-sectional observational study

Olivier Paccoud, Liliwe Shuping, Rudzani Mashau, Greg Greene, Vanessa Quan, Susan Meiring, Nelesh P Govender, for GERMS-SA

Clinical Microbiology and Infection · 2023

DOI: 10.1016/j.cmi.2023.04.016 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Microbiology and Infection, 2023. Verfasst von Olivier Paccoud und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, A Division of the Na…. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, AIDS-Related Opportunistic Infections, HIV Infections, Fungemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: We investigated whether patients with cryptococcal meningitis (CM) or fungaemia detected through South Africa's laboratory cryptococcal antigen (CrAg) screening programme had better outcomes than those presenting directly to the hospital. METHODS: We compared 14-day in-hospital case-fatality ratios of HIV-seropositive individuals with CD4 counts below 100 cells/μL and laboratory-confirmed CM/fungaemia from 2017-2021, with or without evidence of a positive blood CrAg test within 14 days prior to diagnosis. We evaluated whether the impact of prior CrAg screening on mortality varied according to the study period (pre-COVID-19: before March 2020 vs. COVID-19: after March 2020). RESULTS: Overall, 24.5% (830/3390) of patients had a prior positive CrAg test within 14 days of diagnosis. CrAg-screened patients were less likely to have an altered mental status at baseline than non-CrAg-screened patients (38.1% [296/776] vs. 42.6% [1010/2372], p = 0.03), and had a lower crude 14-day case-fatality ratio (24.7% [205/830] vs. 28.3% [724/2560]; OR, 0.83 [95% CI, 0.69-0.99]; p = 0.045). Previous CrAg screening was associated with a greater reduction in the crude 14-day mortality during the COVID-19 period (OR, 0.64 [0.47-0.87]; p = 0.005) compared with before (OR, 0.95 [0.76-1.19]; p = 0.68). After adjustment, previous CrAg screening within 14 days was associated with increased survival only during the COVID-19 period (adjusted OR, 0.70 [0.51-0.96]; p = 0.03). DISCUSSION: Previous CrAg screening was associated with a survival benefit in patients hospitalized with CM/fungaemia during the COVID-19 period, with fewer patients having an altered mental status at baseline, suggesting that these patients may have been diagnosed with cryptococcosis earlier.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meningitis, CryptococcalAIDS-Related Opportunistic InfectionsHIV InfectionsFungemiaCOVID-19CryptococcusHumansHospital MortalitySouth AfricaAntifungal AgentsAntigens, FungalCD4 Lymphocyte Count

Stichwörter der Autor:innen

Cryptococcal antigen screeningCryptococcal fungaemiaCryptococcal meningitisCryptococcosisHuman immunodeficiency virus

Substanzen

Antifungal AgentsAntigens, Fungal

Autor:innen und Institutionen

  • Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, A Division of the National Health Laboratory Service, Johannesburg, South Africa; Universi…
  • Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, A Division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, A Division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, A Division of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of He…
  • Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, A Division of the National Health Laboratory Service, Johannesburg, South Africa; School o…

Förderung

  • Medical Research Council

Zitieren

APA

Paccoud, O., Shuping, L., Mashau, R., Greene, G., Quan, V., Meiring, S., Govender, N. P., & for GERMS-SA (2023). Impact of prior cryptococcal antigen screening on in-hospital mortality in cryptococcal meningitis or fungaemia among HIV-seropositive individuals in South Africa: a cross-sectional observational study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2023.04.016

Vancouver

Paccoud O, Shuping L, Mashau R, Greene G, Quan V, Meiring S, et al. Impact of prior cryptococcal antigen screening on in-hospital mortality in cryptococcal meningitis or fungaemia among HIV-seropositive individuals in South Africa: a cross-sectional observational study. Clinical Microbiology and Infection. 2023. doi:10.1016/j.cmi.2023.04.016

BibTeX
@article{Paccoud2023,
  author = {Paccoud, Olivier and Shuping, Liliwe and Mashau, Rudzani and Greene, Greg and Quan, Vanessa and Meiring, Susan and Govender, Nelesh P and for GERMS-SA, for GERMS-SA},
  title = {Impact of prior cryptococcal antigen screening on in-hospital mortality in cryptococcal meningitis or fungaemia among HIV-seropositive individuals in South Africa: a cross-sectional observational study},
  journal = {Clinical Microbiology and Infection},
  year = {2023},
  doi = {10.1016/j.cmi.2023.04.016}
}
Kostenlos starten →